angiotensin ii has been researched along with mycophenolic acid in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (85.71) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chávez, M; Egido, J; Gómez-Garre, D; Gordon, K; Herrera-Acosta, J; Johnson, RJ; Largo, R; Parra, G; Pons, H; Quiroz, Y; Rincón, J; Rodríguez-Iturbe, B | 1 |
| Franco, M; García-Torres, R; Gordon, KL; Herrera-Acosta, J; Johnson, RJ; Pons, H; Rodríguez-Iturbe, B; Santamaría, J; Tapia, E; Zafra, I | 1 |
| Bonet, L; Chávez, M; Herrera-Acosta, J; Johnson, RJ; Nava, M; Pons, HA; Quiroz, Y; Rodríguez-Iturbe, B | 1 |
| Fujihara, CK; Noronha, IL; Zatz, R | 1 |
| Dechend, R; Fiebeler, A; Finckenberg, P; Haller, H; Hampich, F; Heidecke, H; Ju, X; Kreuzer, J; Luft, FC; Mervaala, E; Muller, DN; Park, JK; Shagdarsuren, E; Theuer, J; Viedt, C; Zenke, M | 1 |
| Chang, CT; Wu, MS; Yang, CW | 1 |
| Ahn, HJ; Bang, BK; Cha, JH; Jung, JY; Kim, J; Kim, WY; Kim, YS; Li, C; Yang, CW; Yoon, SA | 1 |
| Bonnet, J; Combe, C; Delmas, Y; Dubus, I; Gordien, M; L'Azou, B; Labouyrie, JP | 1 |
| Ferrebuz, A; Quiroz, Y; Rodríguez-Iturbe, B; Vanegas, V | 1 |
| Bautista, R; Franco, M; Galicia, O; Johnson, RJ; Martínez, F; Quiroz, Y; Rodríguez-Iturbe, B | 1 |
| Bravo, Y; Ferrebuz, A; Quiroz, Y; Rodríguez-Iturbe, B; Vaziri, ND | 1 |
| Burchette, JL; Coffman, TM; Crowley, SD; Frey, CW; Gould, SK; Griffiths, R; Howell, DN; Kim, HS; Makhanova, N; Ruiz, P; Tharaux, PL; Yan, M | 1 |
| Cook, AK; Giddens, MI; Guan, Z; Hobbs, JL; Inscho, EW; Osmond, DA; Pollock, DM; Pollock, JS; Yamamoto, T; Zhang, S | 1 |
| Dugas, CM; Franco, M; Katsurada, A; Navar, LG; Satou, R | 1 |
1 review(s) available for angiotensin ii and mycophenolic acid
| Article | Year |
|---|---|
The inflammatory component in progressive renal disease--are interventions possible?
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Fibrosis; Humans; Inflammation; Inflammation Mediators; Kidney Diseases; Models, Biological; Mycophenolic Acid; Nephritis; Renin-Angiotensin System; Transforming Growth Factor beta | 2002 |
13 other study(ies) available for angiotensin ii and mycophenolic acid
| Article | Year |
|---|---|
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Body Weight; Cell Division; Creatinine; Disease Models, Animal; Fibronectins; Hypertension, Renal; Kidney; Leukocytes, Mononuclear; Lipid Peroxidation; Male; Malondialdehyde; Mycophenolic Acid; Osteopontin; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sialoglycoproteins; Superoxides; Vasoconstrictor Agents | 2001 |
Renal cortical vasoconstriction contributes to development of salt-sensitive hypertension after angiotensin II exposure.
Topics: Angiotensin II; Animals; Drug Synergism; Hemodynamics; Hypertension; Immunosuppressive Agents; Kidney; Kidney Cortex; Kidney Glomerulus; Male; Mycophenolic Acid; Rats; Rats, Sprague-Dawley; Sodium Chloride; Vasoconstriction | 2001 |
Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats.
Topics: Angiotensin II; Animals; Arterioles; Blood Pressure; Catalase; Glutathione; Hypertension, Renal; Immunocompetence; Immunosuppressive Agents; Kidney; Lymphocytes; Macrophages; Male; Malondialdehyde; Mycophenolic Acid; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Superoxides | 2002 |
Immunosuppressive treatment protects against angiotensin II-induced renal damage.
Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Antigens, CD; B7-2 Antigen; Blood Pressure; Dendritic Cells; Dexamethasone; Etanercept; Histocompatibility Antigens Class II; Humans; Immunoglobulin G; Immunosuppressive Agents; Inflammation; Kidney; Kidney Diseases; Kinetics; Macrophage Migration-Inhibitory Factors; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mycophenolic Acid; NADPH Dehydrogenase; NADPH Oxidases; NF-kappa B; Phosphoproteins; Protective Agents; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Tumor Necrosis Factor; Renin; T-Lymphocytes | 2002 |
Mycophenolic acid reduces renin-angiotensin-system activity in cultured mouse medullary thick ascending limb cells.
Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; Kidney Medulla; Kinetics; Mice; Mycophenolic Acid; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2002 |
Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Body Weight; Chronic Disease; Cyclosporine; Drug Synergism; Fibrosis; Gene Expression; Immunosuppressive Agents; Kidney; Kidney Diseases; Losartan; Macrophages; Male; Mycophenolic Acid; Osteopontin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
Cytoskeletal reorganization by mycophenolic acid alters mesangial cell migration and contractility.
Topics: Angiotensin II; Cell Line; Cell Movement; Cell Size; Cytoskeletal Proteins; Cytoskeleton; Glomerular Mesangium; Humans; Immunosuppressive Agents; Mycophenolic Acid; Myosin Light Chains; Phosphorylation | 2003 |
Hypertension in Page (cellophane-wrapped) kidney is due to interstitial nephritis.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cellophane; Disease Models, Animal; Glutathione; Hypertension, Renal; Immunosuppressive Agents; Ischemia; Kidney; Kidney Function Tests; Male; Malondialdehyde; Mycophenolic Acid; Nephritis, Interstitial; Pressure; Rats; Rats, Sprague-Dawley | 2005 |
Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Hypertension, Renal; Immunohistochemistry; Infusion Pumps, Implantable; Kidney; Lymphocytes; Macrophages; Male; Microdialysis; Mycophenolic Acid; Rats; Rats, Sprague-Dawley; Sodium, Dietary | 2007 |
Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Creatinine; Hypertension; Immunosuppressive Agents; Inflammation; Kidney Diseases; Lead; Lymphocytes; Macrophages; Male; Malondialdehyde; Mycophenolic Acid; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Superoxides; Transcription Factor RelA | 2007 |
Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension.
Topics: Albuminuria; Angiotensin II; Animals; Cardiomegaly; Cell Proliferation; Cytoskeleton; Disease Models, Animal; Hypertension; Immunosuppressive Agents; Interferon-gamma; Kidney Diseases; Male; Mice; Mice, Knockout; Mycophenolic Acid; Sodium Chloride, Dietary; T-Lymphocytes; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents | 2008 |
Immunosuppression preserves renal autoregulatory function and microvascular P2X(1) receptor reactivity in ANG II-hypertensive rats.
Topics: Adenosine Triphosphate; Albuminuria; Angiotensin II; Animals; Arterioles; Homeostasis; Hypertension; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocyte Activation; Lymphocytes; Macrophages; Male; Mycophenolic Acid; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X1; Renal Circulation; Transforming Growth Factor beta1 | 2013 |
Immunosuppression by Mycophenolate Mofetil Mitigates Intrarenal Angiotensinogen Augmentation in Angiotensin II-Dependent Hypertension.
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Hypertension; Immunosuppression Therapy; Kidney; Kidney Diseases; Mycophenolic Acid; Proteinuria; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2022 |